411 results on '"Hartmann, Rune"'
Search Results
2. PD-L1 and PD-L2 immune checkpoint protein induction by type III interferon in non-small cell lung cancer cells
3. The presence of interferon affects the progression of non-alcoholic fatty liver disease
4. The role of IFNL4 in liver inflammation and progression of fibrosis
5. Establishment of well-differentiated camelid airway cultures to study Middle East respiratory syndrome coronavirus
6. Two cGAS-like receptors induce antiviral immunity in Drosophila
7. HSV‐1 ICP27 targets the TBK1‐activated STING signalsome to inhibit virus‐induced type I IFN expression
8. Cross-species analysis of viral nucleic acid interacting proteins identifies TAOKs as innate immune regulators
9. STEEP mediates STING ER exit and activation of signaling
10. Defective interferon priming and impaired antiviral responses in a patient with an IRF7 variant and severe influenza
11. RNase L-activating 2′–5′ oligoadenylates bind ABCF1, ABCF3 and Decr-1
12. Interferon-λ enhances adaptive mucosal immunity by boosting release of thymic stromal lymphopoietin
13. Frequently used bioinformatics tools overestimate the damaging effect of allelic variants
14. Viral recognition and the antiviral interferon response
15. Author Correction: STEEP mediates STING ER exit and activation of signaling
16. RNase L activating 2'-5' oligoadenlyates bind ABCF1, -3 and Decr-1
17. Cellular Mechanism for Impaired Hepatitis C Virus Clearance by Interferon Associated with IFNL3 Gene Polymorphisms Relates to Intrahepatic Interferon-λ Expression
18. Cryo‐EM structure of the human NKCC1 transporter reveals mechanisms of ion coupling and specificity
19. Effective Interferon Lambda Treatment Regimen To Control Lethal MERS-CoV Infection in Mice
20. Cryo-EM structure of the human NKCC1 transporter reveals mechanisms of ion coupling and specificity
21. Guarding the frontiers: the biology of type III interferons
22. Redirector of Vaccine-Induced Effector Responses (RoVER) for Specific Killing of Cellular Targets
23. Correction: SARS-CoV-2 suppresses IFNβ production mediated by NSP1, 5, 6, 15, ORF6 and ORF7b but does not suppress the effects of added interferon
24. B Cell Intrinsic STING Signaling Is Not Required for Autoreactive Germinal Center Participation
25. Cryo-EM structure of the human NKCC1 transporter reveals mechanisms of ion coupling and specificity
26. The Impact of IFNλ4 on the Adaptive Immune Response to SARS-CoV-2 Infection
27. OAS proteins and cGAS: unifying concepts in sensing and responding to cytosolic nucleic acids
28. IFN-λ4 positive pDC stimulated with HCV infected cells mount reduced IFN-α responses: ID: 231
29. Comparing the stability and activity of recombinant IFNλ3 and IFNλ4: ID: 191
30. Investigating the role of interferon λ4 in hepatitis C virus infection: ID: 101
31. Unique and overlapping roles of type I and type III interferons in influenza pathology and therapy: ID: 151
32. The IFNL4 paradox: An active interferon yet a disadvantage during HCV infection: ID: 180
33. Interferon-λ Improves the Efficacy of Intranasally or Rectally Administered Influenza Subunit Vaccines by a Thymic Stromal Lymphopoietin-Dependent Mechanism
34. SARS-CoV-2 suppresses IFNβ production mediated by NSP1, 5, 6, 15, ORF6 and ORF7b but does not suppress the effects of added interferon
35. Disparate temperature-dependent virus-host dynamics for SARS-CoV-2 and SARS-CoV in the human respiratory epithelium
36. SARS-CoV-2 elicits robust adaptive immune responses regardless of disease severity
37. Selective Janus kinase inhibition preserves interferon-λ–mediated antiviral responses
38. Effective interferon (IFN)-lambda treatment regimen to control lethal MERS-CoV infection in mice
39. Cross-species analysis of viral nucleic acid interacting proteins identifies TAOKs as innate immune regulators
40. Author Correction:STEEP mediates STING ER exit and activation of signaling (Nature Immunology, (2020), 21, 8, (868-879), 10.1038/s41590-020-0730-5)
41. A P70S Variant of the IFNλ4 Protein Displaying Decreased Activity is Associated with Improved Hepatitis C Virus Clearance and Reduced Hepatic Expression of Interferon-Stimulated Genes: 226
42. Antiviral Activity of Human OASL Protein Is Mediated by Enhancing Signaling of the RIG-I RNA Sensor
43. Disparate temperature-dependent virus–host dynamics for SARS-CoV-2 and SARS-CoV in the human respiratory epithelium
44. Interferon lambda 4 genotype and pathway in alcoholic hepatitis
45. Weak Induction of Interferon Expression by SARS-CoV-2 Supports Clinical Trials of Interferon Lambda to Treat Early COVID-19
46. 2′3′-cGAMP triggers a STING- and NF-κB–dependent broad antiviral response in Drosophila
47. Insights into the Evolution of Class II Cytokines: Crystal Structure of Interleukin 22 from Zebrafish: 248
48. A novel role for the oligoadenylate synthetase-like protein in viral recognition and interferon induction: 85
49. The extracellular domains of the IL-21 receptor are bridged by glycosylation through conserved anchor points.: CS16-3
50. Mapping the active site and investigating the polyI:C inducibility of the human 120 kDa 2’-5’ Oligoadenylate Synthetase 3: PS2-008
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.